“The Biopharmaceuticals Excipients market is expected to grow at a CAGR of 12.2%” says new Visiongain report

15 April 2020
Pharma

Visiongain has launched a new pharma report: Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.

Pharmaceutical excipients (also known as bulking agent, filler, diluent) are substances formulated with the active ingredient of a drug. They are included in a pharmaceutical dosage form for a special purpose, such as to aid the manufacturing process and to support enhance stability of drugs. Excipients are also useful for product identification and for the enhancement of overall safety and functionality of the product during usage and storage.

The lead analyst of the report commented "Major factors fuelling growth in this market include overall growth in the biopharmaceutical industry and the increasing burden of chronic diseases which surges the demand for innovative and advanced drugs for treatment. The major challenge faced in this industry is the high cost of drug manufacturing, which is compounded by a strict regulatory environment. Government initiatives and increasing research in the development of innovative biopharmaceutical drugs are promising opportunities for market growth."

Leading companies featured in the report include ABITEC Corp, Signet Chemical Corporation, Roquette Freres SA, Sigachi Industries, MEGGLE AG & Other Companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

Read

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

Read

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever